BiotechTube
Home/T-Knife Therapeutics/Elisa Kieback, Ph.D.
EK

Elisa Kieback, Ph.D.

Chief Technology Officer & Co-founder

T-Knife Therapeutics

Therapeutic Areas

Oncology

T-Knife Therapeutics Pipeline

DrugIndicationPhase
TK-6302PRAME-positive solid tumorsPre-clinical

Leadership Team at T-Knife Therapeutics

TS
Thomas Soloway
Chief Executive Officer
CL
Camille Landis
Chief Business Officer / Chief Financial Officer
PS
Peggy Sotiropoulou, Ph.D.
Chief Scientific Officer
View full T-Knife Therapeutics profile